Danske Bank A S Acquires New Position in Envista Holdings Corporation $NVST

Danske Bank A S acquired a new stake in Envista Holdings Corporation (NYSE:NVST) during the 2nd quarter, Holdings Channel reports. The firm acquired 248,737 shares of the company’s stock, valued at approximately $6,554,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of NVST. Parallel Advisors LLC increased its position in shares of Envista by 13.1% during the 4th quarter. Parallel Advisors LLC now owns 3,175 shares of the company’s stock valued at $69,000 after purchasing an additional 367 shares during the last quarter. Bank of Montreal Can raised its stake in shares of Envista by 1.4% in the fourth quarter. Bank of Montreal Can now owns 26,178 shares of the company’s stock worth $568,000 after purchasing an additional 372 shares during the last quarter. Sepio Capital LP raised its position in Envista by 1.2% during the fourth quarter. Sepio Capital LP now owns 31,632 shares of the company’s stock valued at $687,000 after acquiring an additional 374 shares in the last quarter. Deutsche Bank AG boosted its position in Envista by 2.9% during the fourth quarter. Deutsche Bank AG now owns 17,412 shares of the company’s stock worth $378,000 after purchasing an additional 484 shares in the last quarter. Finally, State of Michigan Retirement System increased its stake in Envista by 1.5% during the 1st quarter. State of Michigan Retirement System now owns 39,463 shares of the company’s stock worth $1,001,000 after buying an additional 600 shares in the last quarter.

Envista Stock Performance

Shares of NVST stock opened at $27.21 on Friday. The stock has a 50-day moving average of $26.90 and a 200-day moving average of $26.28. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.43 and a quick ratio of 2.07. The stock has a market cap of $4.37 billion, a PE ratio of 46.91, a price-to-earnings-growth ratio of 1.28 and a beta of 0.86. Envista Holdings Corporation has a one year low of $18.77 and a one year high of $30.42.

Envista (NYSE:NVST) last issued its quarterly earnings data on Wednesday, August 5th. The company reported $0.41 EPS for the quarter, topping analysts’ consensus estimates of $0.34 by $0.07. Envista had a net margin of 3.33% and a return on equity of 7.88%. The business had revenue of $730.50 million for the quarter, compared to analyst estimates of $716.11 million. During the same period last year, the business posted $0.26 earnings per share. The firm’s quarterly revenue was up 7.1% on a year-over-year basis. Envista has set its FY 2026 guidance at 1.500-1.550 EPS. As a group, sell-side analysts expect that Envista Holdings Corporation will post 1.53 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities analysts have commented on NVST shares. Morgan Stanley set a $23.00 price target on shares of Envista in a research report on Thursday, August 6th. Barclays cut their price target on Envista from $34.00 to $32.00 and set an “overweight” rating for the company in a report on Thursday, June 11th. Robert W. Baird set a $34.00 price objective on shares of Envista in a research note on Thursday, August 6th. Zacks Research raised shares of Envista from a “hold” rating to a “strong-buy” rating in a report on Friday, August 7th. Finally, Evercore reaffirmed an “outperform” rating and issued a $33.00 price objective on shares of Envista in a report on Thursday, May 7th. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and nine have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $29.31.

Envista Company Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.